Summary The prognostic value of several clinical and histopathological characteristics has been evaluated in patients with Dukes' B and C carcinoma of the rectum and the rectosigmoid. Data on 260 Dukes' B and 208 Dukes' C tumours entered into a prospective, randomized clinical trial of post-operative radiotherapy (5OGy given with 2Gy/fraction in an overall time of 7 weeks) were analyzed by means of the Cox proportional hazards model. The Dukes' stages B and C were analyzed in two separate multivariate analyses. In patients with Dukes' B tumours, a poor prognosis was associated with age above 60, perineural and venous invasion, tumour located <Ocm from the anal verge and elevated pre-operative carcinoembryonic antigen (CEA) (>3.2 ng ml-1). In patients with Dukes' C tumours, perineural and venous invasion, tumour located <Ocm from the anal verge, and elevated pre-operative CEA were associated with a poor prognosis. In addition, a large tumour diameter had a strong, negative influence on the prognosis. Males seemed to have a poorer prognosis than females among the Dukes' C patients. Resection of neighbouring organs was also associated with a poor prognosis in this stage.
The role of adjuvant therapy in colorectal cancer remains controversial. The Danish Cooperative Group on Colorectal Cancer (CRES) conducted a prospective, randomized trial to elucidate whether the deleterious effects of post-operative radiotherapy were justified by an improved survival and/or a delay in the first recurrence (Balslev et al., 1982 (Balslev et al., , 1986 . Even after the inclusion of 494 patients with Dukes' B and C tumours, no significant improvement in the survival after post-operative radiotherapy was demonstrated. The conclusion from this series was that the majority of Dukes' B and C colorectal cancers did not benefit from post-operative radiotherapy, at least when the dose was 50Gy given in 25 fractions in an overall treatment time of seven weeks. More intensive radiotherapy should be carefully considered taking into account the relatively high level (about 10%, Balslev et al., 1986 ) of severe complications. However, large variations in prognosis among Dukes' B or C colorectal cancer patients have been demonstrated. The present regression analysis of survival data was undertaken to define a subset of patients with a potentially poor prognosis in whom more aggressive adjuvant therapy nay be indicated.
Materials and methods
The randomized multicentre study of post-operative radiotherapy in Dukes' B (Dukes' C) . The original classification of Dukes' was employed, with B tumours defined as having penetrated the bowel wall completely, and C tumours as having metastasized to the regional lymph nodes regardless of the degree of bowel wall penetration. No subdivision of Dukes' stages was used. A total of 497 patients with Dukes' B, and 364 patien-ts with Dukes' C tumours were referred to five major surgical departments and operated for cure, and these comprised the candidates for randomization. Of these 276 Dukes' B and 218 Dukes' C were randomized. Exclusion criteria were: tumour above the pelvis, patient aged >80 years, non-radical surgery, bedridden more than 50% of day 20-25 days after surgery, post-operative complications, previous cancer within 5 years and previous radiotherapy. A detailed description of material and methods has been published in Balslev et al. (1982 Balslev et al. ( , 1986 ). In the group of patients randomized to receive radiotherapy 92% actually received treatment, and 84% were treated to the prescribed target dose. A detailed account of escape clauses in the present series has recently been given by Kronborg et al. (1988) .
A number of clinical, pathological and histochemical parameters were evaluated prospectively and stored in a data base for subsequent analysis. In addition, carcinoembryonic antigen (CEA) was measured with the Hoffman-La Roche sandwich-enzyme immunoassay immediately before surgery and at each follow-up. Only the pre-operative CEA is included in the analysis of prognostic factors.
The present analysis is performed on patient data transferred from the CRES data base in Odense to the computer facility at the Radiophysics Laboratory in Aarhus.
Total group, analysis group Patient characteristics for all randomized patients are given in Table I . 
Statistical method
The effect of single variables on survival was investigated by single-parameter analyses using the product-limit estimate of the survivorship function (Kaplan & Meier, 1958) and the log-rank test for statistical significance (Mantel, 1966) . Estimated 5-year survival is specified + the standard error of the estimate. A significance level of 0.05 was employed.
A multivariate regression analysis of survival data was performed using the Cox proportional hazards model (PHM) (Cox, 1972) implemented as a FORTRAN program based on the code given by Kalbfleisch and Prentice (1980) . The proportional hazards assumption was tested graphically. A more detailed description of the procedure has been given recently (Bentzen et al., 1988) .
The covariates, i.e., the clinical and histopathological parameters to be tested for their prognostic value, were selected based on the experience from published prognostic studies (Chapuis et al., 1985; Sugarbaker et al., 1985 Post-operative radiotherapy All patients were treated with 8-16 MV photons in the prone position either with a three-field technique using one posterior and two parallel opposing lateral wedged fields or with a four-field technique using two parallel opposing lateral fields and two parallel opposing anterior-posterior fields. All fields were treated in each treatment session. The target volume specified by the CRES protocol included the pelvic cavity with the proximal field limit at the mid-level of the 5th lumbar vertebra. The distal limit was the lower margin of the obturator foramen in patients having anterior and low anterior resection, whereas in patients having abdominoperineal resection the distal limit included the perineal region. Laterally, the pelvic brim was included with a margin of 1.5 to 2cm. The lateral fields included the posterior surface of the symphysis and the whole sacral cavity with proximal and distal limits matching those of the posterior field. Individually shaped shielding blocks were made to encompass the target defined on conventional simulator radiographs with a 2-3cm margin.
A total target dose of 50Gy was given with 2Gy/fraction, 5 days a week. The irradiation was given as a split-course, A random sample of 45 simulator films and port films were reviewed by the radiotherapy group. In all but two cases (96%) the target volume was judged to be adequately treated. In one patient, the perineal region was erroneously excluded from the field; in the other the margin to the sacral bone was insufficient (-0.5cm).
Results Figure 1 shows the product-limit estimate of the survivorship functions for Dukes' B and Dukes' C patients with or without post-operative radiotherapy. The overall 5-year actuarial survival was 68.9 + 4.6% in Dukes' B patients randomized to receive radiotherapy (+ RT) and 71.4 + 4.7% in those randomized to surgery alone (-RT) the difference being insignificant (2= 0.83, P=0.36). In Dukes' C patients the 5-year survival was 36.3+5.3% (+RT) and 23.4+6.0% (-RT). Again the difference was not statistically significant (X2=O.Ol, P=0.92).
Single parameter analyses were performed to establish an appropriate scoring of age (Table III) and tumour size (Table IV) for the PHM analysis.
In the Dukes' B group old patients (age above 70) had a significantly poorer prognosis than younger patients. A linear test-for-trend based on the log-rank test (Tarone, 1975 ) yielded a highly significant P value (x2= 11.2, P=0.0008). Increasing tumour size evaluated as the maximum diameter of the tumour seemed to be associated with an improved prognosis, but a linear test-for-trend yielded a non-significant P value of 0.11 (X2 = 2.55).
Age had no significant prognostic value in patients with Dukes' C tumours (test-for-trend x2=0.0, P= 1.0). All 10-year age groups had comparable 5-year survival around 30% and median surival around 3 years. Increasing tumour size seemed to worsen prognosis, but again the test-for-trend was non-significant (X2 =2.71, P=0.10).
Regression analysis Patients with Dukes' B and Dukes' C tumours were analyzed as two separate groups. Although this strategy may lead to some loss of statistical power compared to the technically feasible stratified PHM analysis (Kalbfleisch & Prentice, 1980) , it was preferred here in order to avoid the assumption about identical regression coefficients for the two stages. A partial motivation for this choice is the apparent interaction between age and stage (Table III) and tumour size and stage (Table IV) where opposite trends are seen in the two stages. Patient age was entered in the PHM both as a categorical and as a continuous variable. Age had no prognostic value in the Dukes' C group. In the Dukes' B group, patients aged above 60 years experienced an increasing hazard with increasing age. The age dependence was highly significant (P=0.0004). In patients below 60 years of age no correlation was found between age and prognosis.
The male/female ratio was 1.28 among the patients with Dukes' B tumours. Sex had no prognostic value in this group (P=0.25). In Dukes' C patients, a male/female ratio of 0.90 was found. Sex was included in the final regression model with a P value of 0.07 because other authors (e.g., Chapuis et al., 1985) have found this to be a prognostic factor. Females had a better prognosis than males.
Anatomical location of the primary tumour may be characterized in different (highly correlated) ways, e.g., whether the tumour is located in the rectum or the colon, or by the While insignificant in the Dukes' B group (P=0.39), the necessity of neighbour organ resection was associated with a poor prognosis in Dukes' C patients (P=0.06).
Complicating disease, i.e., the presence of conditions assumed to influence the prognosis-but not directly tumour related -was also tested in the analysis. This covariate had no statistical significance.
Three histopathological parameters were available for analysis. Perineural and venous invasion, and histological grading. Perineural invasion had very strong prognostic significance in both groups. Both venous and perineural invasion were strong prognosticators in Dukes' C tumours. When survival was corrected for these two factors, the histologic grade had no significant influence on survival (P=0.16). In Dukes' B tumours a relatively close correlation (r=0.39 estimated from the empirical covariance matrix) was found between venous invasion and histological grade. In view of the importance of venous invasion in Dukes' C disease, this covariate was given the higher priority and included in the final model.
Pre-operative CEA level was classified in 3 groups; 0-3.1 ng ml-1, 3.2-7.0 ng ml -1 and 7.1 + ng ml1. The cutpoints were chosen to be the median (3.1 ngml-1) and the 75th percentile (7.1 ng ml -1) of the CEA values in the combined set of Dukes' B and C patients. The hazard rate was found to increase with increasing CEA. In Dukes' B tumours, a patient with a plasma CEA above 7.1 ng ml -1 (20% of the Dukes' B cases) had a 1.92 times as high hazard rate as a patient in the 0-3.1 ng ml1 group. Similarly, a Dukes' C patient with CEA in the highest group (35% of the Dukes' C cases) had a 1.51 times as high hazard rate as a patient in the low CEA group.
Radiotherapy was added as a covariate in the final regression model. In Dukes' B patients the P value for this covariate was 0.23. The estimated hazard of a patient having radiotherapy was 1.20 times that of a patient having surgery only. In Dukes' C patients the P value of the covariate radiotherapy was 0.46. The estimated hazard of a patient receiving radiotherapy was 1.02 times that of a patient having surgery only.
The final regression parameters are presented in The patient characteristics of these four hypothetical cases are given in Table VII . Indeed, prognostically good Dukes' C patients are likely to do better than prognostically poor Dukes' B patients. Thus, the regression models suggest very important differences in prognosis in patients with identical Dukes' stage.
In assessing the prognostic significance of patients' age as demonstrated in Dukes' B cancer in this analysis, it should be kept in mind that the survival analysis uses death with cancer as the endpoint. Thus, the survival calculated here may be expected to be lower than a standard relative survival. Still, it is interesting that the present worsening of prognosis with increasing age contradicts the findings by Block and Enker (1971) in rectal cancer and by Jensen et al. (1970) in colon cancer. As pointed out by Sugarbaker et al. (1985) the improved prognosis with increasing age observed by these authors may be partly explained by the observation by Dukes and Bussey (1958) that lower grade of malignancy is associated with older age. In a multivariate analysis this confounding effect will be corrected for, but in the current series prognosis worsened with increasing age also in the single-parameter analysis (Table III) . Interestingly, the multivariate analysis by Chapuis et al. (1985) showed the same result as our analysis.
A poorer prognosis in young patients (below 40 years of age) could not be demonstrated in the present series. However, the number of young patients was low, implying a low power of the test.
Sex had a prognostic value in the series by Chapuis et al. (1985) . However, in the present analysis, this result was not reproduced in Dukes' B tumours, and in Dukes' C tumours, sex was the least important of the parameters in the model.
Among the clinical variables, the distance of the tumour from the anal verge is important in both stages. This is probably a consequence of difficulty in securing a tumour free lateral resection margin in low situated tumours. (Quirke et al., 1986 ), but a difference in lymphatic drainage between low and high situated tumours may also influence the prognosis (Sugarbaker et al., 1985) .
A number of authors have failed to demonstrate a clear relationship between tumour size and prognosis. Spratt and (Grinnell, 1950) . When both perineural and venous invasion were entered into the PHM the first turned out to have the strongest prognostic influence.
In addition to being the result of a subjective evaluation, histologic grade is known to be strongly correlated with stage in colorectal cancer (Newland et al., 1981) , and its independent prognostic value is questionable. Nevertheless, Chapuis et al., (1985) (Jass et al., 1986) .
Elevated pre-operative CEA has been shown to be correlated with time to recurrence, in Dukes' B and C cancer (Wanebo, 1978) Cross-validation of this observation in an independent series would be desirable.
In recent years, a number of immunohistochemical markers has been suggested in colorectal cancer. This paper has demonstrated the presence of very strong prognostic factors in this disease. Therefore a multivariate analysis with adequate correction for the effect of known clinical and histological prognosticators is required to assess the independent value of any proposed prognosticator.
Numerous studies using historical controls (Green, 1981; Sichy, 1982; Kopelson, 1983; Hoskins et al., 1985; Tepper et al., 1987) and the randomized study by Gerard et al. (1985) have suggested an improved local control after radiotherapy in colorectal cancer. However, the randomized study by the Gastrointestinal Study Group (1985) showed no significant difference in time to tumour recurrence between the radiation plus surgery (50 pts) and the surgery-alone (58 pts) arms. Only when chemotherapy and radiotherapy were combined in the adjuvant treatment a significant difference in time to recurrence was found. Overall survival did not differ significantly among the treatment arms. The present analysis could not demonstrate any positive effect on survival after post-operative radiotherapy. Without entering the discussion on the methodological problems of using historical controls, it is interesting to note that the lack of difference in survival between the two arms in this study seems to spring not from a poor (relative to that of other studies) result in the radiotherapy arm but rather from a good result in the surgery-alone arm. Thus, if appropriate surgery is performed, radiotherapy seems to have no positive effect on survival. Delivering the radiation as a split course may have reduced the efficacy of the treatment. However, the actual importance of overall treatment time in radiotherapy of colorectal cancer remains an open question. The relevance of radiotherapy should not be judged solely from its influence on survival. Local control is of obvious importance to the patient and is a more sensitive clinical endpoint for measuring the effect of radiotherapy. Furthermore, an analysis of local control might be of value in identifying subsets of patients in which intensified local treatment would be indicated. An analysis of this endpoint with correction for other prognostic factors awaits a revision of the database.
In conclusion, clinical and histopathological variables collected prospectively in a randomized multi-centre study of post-operative radiotherapy in Dukes' B and C colorectal cancer were evaluated with respect to their prognostic importance using death with cancer as the endpoint. From the set of available parameters a proportional hazards model was derived containing parameters with an independent, significant influence on prognosis. Based on these models a prognostic forecast may be made in individual patients with Dukes' B or (Dukes' B) and maximum tumour diameter (Dukes' C) require a slightly different procedure. The covariate describing the prognostic effect of age is set equal to zero for patients below 60 years of age, and equal to the actual age minus 60 years for patients above 60 years of age (e.g., equal to 13 for a 73-year-old patient). The covariate describing the effect of tumour size is set equal to the maximum tumour diameter measured in cm minus 5 cm (the reference size for the best case in Table VII ), e.g., equal -3 for a 2cm diameter tumour.
Second, multiply the value of each covariate with the corresponding B-value from Table VI and add together all these products. Let s denote the resulting sum.
Third, calculate exp(s) and raise the 5-year survival from Table VII to this power. The result is the estimated survival for the actual case, again expressed as a fraction of one.
Example. Calculate the estimated 5-year survival for a 65-year-old patient with a Dukes' B tumour, a pre-operative CEA level of 8 ng ml-and with venous invasion. There is no perineural invasion and the tumour is located more than 10cm from the anal verge.
Solution: First note that there is no contribution from the covariates describing perineural invasion and localization as these agree with the values for the prognostic best case. The covariate for venous invasion is equal to one, for age the covariate is equal to 5 (actual age minus 60 years), and for CEA it is 2. Thus s is s=0.398 1+0.071 -5+0.327 * 2= 1.407 and exp (s) becomes 4.08. The estimated 5-year survival for the actual case is then the 5-year survival for the prognostic best case raised to the power 4.08, i.e., (0.90)4.08 =0.65 or 65%.
